NCT03131167View on ClinicalTrials.gov

Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 10, 2017

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions
Primary Open-angle Glaucoma (POAG)Ocular Hypertension
Interventions
DRUG

SHP639 (n=60)

Drug SHP639 is a 9-amino acid, synthetic, C-type natriuretic peptide (CNP) analog.

DRUG

Placebo Comparator (n=24)

Drug: Vehicle Ophthalmic placebo solution of the same composition as the test product.

Trial Locations (1)

02421

Central Contact, Lexington

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY